| ECG | Electro-Cardio-Graphy(-Gram); 심전도 = EKG 1. Conducting System Structu... |
|---|---|
| JVP | [POMD P 49 - 52] 1) Jugular Vein Pressure 2) Jugular Venous Pulse ... |
| NAD | neutrophil actin dysfunction; new antigenic determinant; nicotinamide adenine dinucleotide; nicotini... |
| cyt | cytochrome; cytology, cytological; cytoplasm, cytoplasm |
| cytol | cytology, cytological |
| AIMS | Abnormal Involuntary Movement Scale |
|---|---|
| AIM | abnormal involuntary movement |
| AUB | Abnormal Uterine Bleeding |
| Awd | Abnormal wing disc |
| TAM | Transient abnormal myelopoiesis |
| pulmonary embolism: findings | <radiology> Embolism without infarction (90%), normal chest (25%), platelike atelactasis, Westermark sign, knuckle sign, local widening of artery by impacted embolus, segmental / lobar consolidation, pleural effusion embolism with infarction (10%), wedge-shaped consolidation (50%), may cavitate, Hampton hump, pleural effusion (50%), no air-bronchogram, melting sign, Fleischner lines, platelike atelactasis (25%), cardiomegaly / congestive heart failure (20%), elevated hemidiaphragm (20%) see: pulmonary embolism (12 Dec 1998) |
|---|---|
| abnormal | Not normal, contrary to the usual structure, position, behaviour or rule. (06 Oct 1997) |
| abnormal cleavage of cardiac valve | Congenital malformation of a valve leaflet with a defect extending from the free margin. (05 Mar 2000) |
| abnormal correspondence | Abnormal correspondence, a condition, frequent in strabismus, in which corresponding retinal points do not have the same visual direction; the fovea of one eye corresponds to an extrafoveal area of the fellow eye. Synonym: abnormal correspondence. (05 Mar 2000) |
| abnormal heart chamber dimensions | <radiology> Left ventricular volume overload, left ventricular hypertrophy, right ventricular volume overload, right ventricular hypertrophy, fixed subvalvular aortic stenosis, hypoplastic left/right ventricle; common ventricle, congestive cardiomyopathy (12 Dec 1998) |
| abnormal occlusion | An arrangement of the teeth which is not considered to be within the normal range of variation. (05 Mar 2000) |
| abnormal placental size | <radiology> TOO BIG (greater than5cm in sections obtained at right angles to the long axis), maternal disease, diabetic mothers (= villous oedema), intrauterine infections, anaemic mothers (= normal histology), foetal disease, erythroblatosis foetalis (= villous oedema and hyperplasia), umbilical vein obstruction, foetal high output failure, large chorioangioma, sacrococcygeal teratoma, arteriovenous fistula too small, preeclampsia (associated with placental infarcts in 33-60%) (12 Dec 1998) |
| reflex, abnormal | Abnormal, involuntary response to a stimulus which includes hyperreflexia, hyporeflexia, and areflexia. (12 Dec 1998) |
| cellular immunodeficiency with abnormal immunoglobulin synthesis | An ill-defined group of sporadic disorders of unknown cause, occurring in both males and females and associated with recurrent bacterial, fungal, protozoal, and viral infections; there is thymic hypoplasia with depressed cellular (T-lymphocyte) immunity combined with defective humoral (B-lymphocyte) immunity, although immunoglobulin levels may be normal. Synonym: Nezelof syndrome, Nezelof type of thymic alymphoplasia. (05 Mar 2000) |
| haemoglobins, abnormal | Haemoglobins altered in their genetically determined molecular structure, resulting in a characteristic complex of vlinival and laboratory abnormalities. The specific features of the abnormal haemoglobins are related to variation of the composite globin polypeptide chains. (12 Dec 1998) |
| pupillary functions, abnormal | Conditions in which the pupil does not react normally to dilation and constriction. Signs of pupillary abnormalities originate from the pupil's shape, position, and response to stimulation. (12 Dec 1998) |
| fibrinogens, abnormal | Fibrinogens which have a functional defect as the result of one or more amino acid substitutions in the amino acid sequence of normal fibrinogen. Abnormalities of the fibrinogen molecule may impair any of the major steps involved in the conversion of fibrinogen into stabilised fibrin, such as cleavage of the fibrinopeptides by thrombin, polymerization and cross-linking of fibrin. The resulting dysfibrinogenaemias can be clinically silent or can be associated with bleeding, thrombosis or defective wound healing. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|